We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Optoelectrokinetic Tech Underlies New Biochip Approach

By LabMedica International staff writers
Posted on 05 Feb 2013
A recently developed optoelectrokinetic manipulation technique was used to separate microorganisms according to size, which demonstrated the potential of this method for the development of "lab-on-a-chip" diagnostic technologies.

The technique, rapid electrokinetic patterning - or REP, works by focusing an infrared laser to heat a fluid in a microchannel containing particles or bacteria. More...
An electric field is applied that combined with the laser's heating action causes the fluid to circulate in a "microfluidic vortex" that functions like a centrifuge to isolate particles based on size.

A detailed description of the method, which was used to collect three different types of microorganisms: the bacterium Shewanella oneidensis MR-1; the single-cell spherical fungus Saccharomyces cerevisiae; and the spherical bacterium Staphylococcus aureus, was published in the December 7, 2012, issue of the journal Lab on a Chip.

Senior author Dr. Steven T. Wereley, professor of mechanical engineering at Purdue University (West Lafayette, IN, USA), said, "By properly choosing the electrical frequency we can separate blood components, such as platelets. Say you want to collect Shewanella bacteria, so you use a certain electrical frequency and collect them. Then the next day you want to collect platelets from blood. That is going to be a different frequency. We foresee the ability to dynamically select what you will collect, which you could not do with conventional tools. The new results demonstrate that REP can be used to sort biological particles but also that the technique is a powerful tool for development of a high-performance on-chip bioassay system."

"It will not be on the market in a year," said Dr. Wereley. "We are still in the research end of this. We are sort of at the stage of looking for the killer app for this technology."

The REP method may also have applications in the field of nanomanufacturing due to its ability to assemble suspensions of particles known as colloids. This may be particularly relevant to the pharmaceutical industry, as a number of drugs are manufactured from solid particles suspended in liquid. Currently particles are collected and separated from the liquid by a process of filtration and centrifugation—methods not now available for production use at the nano level.

Related Links:

Purdue University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.